Rey JA, Findor JA, Daruich JR, Velazco CC, Igartua EB, Schmee E, Kohan AI
Department of Hemotherapy and Immunohematology, Hospital de Clínicas, School of Medicine, University of Buenos Aires, Argentina.
J Travel Med. 1997 Jun 1;4(2):100-101. doi: 10.1111/j.1708-8305.1997.tb00788.x.
Hepatitis E virus (HEV) is the main etiological agent for the enterically transmitted form of non-A, non-B hepatitis (ET-NANB), and is associated with epidemic and sporadic forms of the disease,1 mainly in some developing countries.2 In Argentina, no ET-NANB hepatitis epidemics have been described, and no epidemiological HEV data are known up to this time. The aim of the present study is to evaluate the prevalence of anti-HEV in different groups of the population of Buenos Aires, an area considered to be nonendemic.
戊型肝炎病毒（HEV）是经肠道传播的非甲非乙型肝炎（ET-NANB）的主要病原体，与该疾病的流行和散发形式相关，主要发生在一些发展中国家。在阿根廷，尚未描述过ET-NANB肝炎的流行情况，目前也没有关于HEV的流行病学数据。本研究的目的是评估布宜诺斯艾利斯不同人群中抗HEV的流行率，该地区被认为是非地方性流行区。
